Physician profile
Steven L Davidoff
NPI 1114956554
$364,115.94
in general payments reported to CMS, 2019-2025
49 companies · $22K in 2025
The $22K reported for 2025 was more than what 97% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,329 · 2020: $18K · 2021: $47K · 2022: $56K · 2023: $108K · 2024: $105K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $207K · Travel and Lodging: $12K · Food and Beverage: $11K · Consulting Fee: $5,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $207,289.00 |
| Travel and Lodging | $11,719.10 |
| Food and Beverage | $10,563.98 |
| Consulting Fee | $5,362.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $342,244.73 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $7,109.63 | 2019-2023 | |
| Genzyme Corporation | $1,796.26 | 2021-2025 | |
| Grifols Shared Services North America, INC. | $1,640.00 | 2023 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals Lp | $1,560.99 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Genentech, INC. | $1,000.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $904.00 | 2019-2025 | Ofev, Jascayd |
| Insmed, INC. | $903.37 | 2020-2025 | Arikayce, Brinsupri |
| Mallinckrodt Hospital Products INC. | $736.95 | 2020-2025 | Acthar |
| Merck Sharp & Dohme LLC | $680.24 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Inari Medical, INC. | $634.53 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mylan Specialty L.P. | $612.84 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $591.25 | 2019-2025 | Prolastin-C Liquid |
| Baxter Healthcare | $494.11 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Regeneron Healthcare Solutions, INC. | $387.21 | 2019-2024 | Dupixent |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $342.49 | 2020-2024 | Xarelto |
| Electromed, INC. | $300.87 | 2021-2025 | Smartvest |
| Ani Pharmaceuticals, INC. | $251.31 | 2022-2025 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $249.96 | 2020-2025 | Glassia |
| Pulmonx Corporation | $208.44 | 2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Viatris Specialty LLC | $149.05 | 2025 | Yupelri |
| Penumbra, INC. | $146.95 | 2025 | Indigo System |
| Philips North America LLC | $135.31 | 2019-2025 | Vest Therapy Und |
| United Therapeutics Corporation | $115.08 | 2024-2025 | Tyvaso, Tyvaso |
| Abbvie INC. | $105.92 | 2023-2025 | Teflaro, Avycaz |
| Gilead Sciences, INC. | $89.94 | 2023-2024 | |
| Advanced Respiratory, INC | $78.24 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $78.19 | 2019-2024 | Uptravi, Opsumit |
| Amgen INC. | $60.51 | 2024-2025 | Tezspire, Tavneos |
| Ambu INC. | $44.93 | 2023 | |
| Shire North American Group INC | $41.92 | 2019 | |
| Paratek Pharmaceuticals, INC. | $41.63 | 2021 | |
| Novartis Pharmaceuticals Corporation | $38.27 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $33.63 | 2019 | |
| Boston Scientific Corporation | $30.85 | 2022 | |
| Ceribell, INC. | $29.20 | 2020-2023 | Ceribell Rapid Response Eeg |
| Optinose US, INC. | $28.28 | 2024 | |
| Allergan, INC. | $26.60 | 2019 | |
| Nabriva Therapeutics, Plc | $25.31 | 2022 | |
| Inogen, INC. | $21.41 | 2022 | |
| Genentech USA, INC. | $21.02 | 2021 | |
| Inspire Medical Systems, INC. | $19.38 | 2023 | Inspire |
| Mayne Pharma Commercial LLC | $16.70 | 2022 | |
| Breas Medical, INC. | $16.04 | 2025 | Vivo 45 Ls |
| Covis Pharma Gmbh | $14.99 | 2020 | |
| Lilly USA, LLC | $14.71 | 2025 | Zepbound |
| Circassia INC. | $14.69 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.16 | 2021 | |
| Tactile Systems Technology INC | $13.85 | 2025 | Flexitouch Plus, Nimbl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Davidoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.